Faron Pharmaceuticals Oy
F:4FR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Faron Pharmaceuticals Oy
F:4FR
|
FI |
|
Redwood Pharma AB
F:9JV
|
SE |
|
B
|
Benz Mining Corp
F:1VU
|
CA |
|
H
|
Honyi Precision Industry Co Ltd
TPEX:4530
|
TW |
|
D
|
Diamond Hill Investment Group Inc
F:BVE
|
US |
|
Wise Group AB
F:5CL
|
SE |
|
ReVolve Renewable Power Corp
F:PM7
|
CA |
|
Duro Felguera SA
LSE:0F7F
|
ES |
|
B
|
Baloise Holding AG
DUS:BLON
|
CH |
|
H
|
Helios Fairfax Partners Corp
F:3UD
|
CA |
|
Sparebank 1 Sorost-Norge
F:EZ4
|
NO |
|
R
|
Robertet SA
PAR:CBE
|
FR |
|
A
|
Artra Group Corp
TSE:6029
|
JP |
|
Convum Ltd
TSE:6265
|
JP |
|
C
|
Celexpress Inc
OTC:CELX
|
US |
|
Strattec Security Corp
NASDAQ:STRT
|
US |
|
T
|
Tekcore Co Ltd
TPEX:3339
|
TW |
|
A
|
Alumina Ltd
F:WMC1
|
AU |
|
R
|
Radiant Innovation Inc
TPEX:3373
|
TW |
|
EnBio Holdings Inc
TSE:6092
|
JP |
|
F
|
Fitvia Corp
OTC:BRZV
|
CN |
|
C
|
CAM Group Inc
OTC:CAMG
|
CN |
|
C
|
Chongqing Iron & Steel Co Ltd
F:CGP
|
CN |
|
B
|
Bionoid Pharma Inc
OTC:BINP
|
US |
Bankruptcy Probability
Faron Pharmaceuticals Oy's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Faron Pharmaceuticals Oy Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FI |
|
Faron Pharmaceuticals Oy
LSE:FARN
|
80.8m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
457.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
230.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Faron Pharmaceuticals Oy's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Faron Pharmaceuticals Oy has total debt of 14.3m EUR. This includes both short-term (0 EUR) and long-term (14.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
